Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
BackgroundThe long-term survival of cancer patients has significantly improved over the past years. Despite their therapeutic efficacy, various cancer therapies are associated with cardiotoxicity. Therefore, timely detection of cardiotoxic adverse events is crucial. However, the clinical assessment...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020-05-01
|
| Col·lecció: | Frontiers in Pharmacology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/article/10.3389/fphar.2020.00740/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|